About: The Strategic Alliance between Clinical and Molecular Science in the War against SARS-CoV-2, with the Rapid-Diagnostics Test as an Indispensable Weapon for Front Line Doctors

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The Strategic Alliance between Clinical and Molecular Science in the War against SARS-CoV-2, with the Rapid-Diagnostics Test as an Indispensable Weapon for Front Line Doctors Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	The Strategic Alliance between Clinical and Molecular Science in the War against SARS-CoV-2, with the Rapid-Diagnostics Test as an Indispensable Weapon for Front Line Doctors
Creator	Battino, Maurizio Giampieri, Francesca Paradiso, Angelo Antignani, Pier Callegaro, Annapaola Dentali, Francesco Tangianu, Flavio Gnasso, Agostino Modena, Maria Casu, Gavino Aluigi, Leonardo Capello, Fabio Cipolla, Enrico Cipolla, Maurizio Cosco, Lucio Culzoni, Federico Elexpuru-Zabaleta, Maria Forbes-Hernandez, Tamara Fragiacomo, Claudia Gaddi, Antonio Mancini, Raffaele Nichelatti, Michele Ortasi, Pasquale Savo, Maria Tempesta, Sergio Voci, Diego
Source	Medline; PMC
abstract	Our work concerns the actual problem of spread of SARS- CoV-2 outbreak which requires fast and correct as possible answer. In current scenario, the need of rapid answer put away the imperative of proper methodology. We focus on the serogical immunoassay for diagnosis of Covid-19 as an important weapon not only for diagnostic purpose, but also for epidemiologic one. The right equilibrium between high speed, low cost and accuracy is obtained with easy-to-use decentralized point-of-care test as the colloidal gold-based immunochromatographic strip assay which detects IgM and IgG antibodies directed against SARS-CoV-2. As our aim is to evaluate the efficacy of Covid-19 rapid tests and of serological assays in real-life settings, we designed a research protocol aimed to establish how to use correctly these diagnostics, taking into account the different possible clinical and epidemiological scenarios.
has issue date	2020-06-22(xsd:dateTime)
bibo:doi	10.3390/ijms21124446
bibo:pmid	32580529
has license	cc-by
sha1sum (hex)	cf721b638562992fcfd565d3cd88fc119b8e87c1
schema:url	https://doi.org/10.3390/ijms21124446
resource representing a document's title	The Strategic Alliance between Clinical and Molecular Science in the War against SARS-CoV-2, with the Rapid-Diagnostics Test as an Indispensable Weapon for Front Line Doctors
has PubMed Central identifier	PMC7352982
has PubMed identifier	32580529
schema:publication	Int J Mol Sci
resource representing a document's body	covid:cf721b638562992fcfd565d3cd88fc119b8e87c1#body_text
is schema:about of	named entity 'directed' named entity 'proper' named entity 'Covid-19' named entity 'immunochromatographic' named entity 'equilibrium' named entity 'OUR' named entity 'WORK' named entity 'HIGH SPEED' named entity 'RAPID' named entity 'SPREAD' named entity 'ASSAY' named entity 'CORRECT' named entity 'DIAGNOSTIC' named entity 'PURPOSE' named entity 'TAKING' named entity 'BASED' named entity 'RESEARCH' named entity 'protocol' named entity 'focus' named entity 'assay' named entity 'answer' named entity 'colloidal' named entity 'weapon' named entity 'colloidal gold' named entity 'epidemiological' named entity 'Covid' named entity 'serological' named entity 'IgM' named entity 'SARS-CoV-2' named entity 'infection' named entity 'spike proteins' named entity 'serological test' named entity 'exposure to the virus' named entity 'antibody' named entity 'enzyme-linked immunosorbent assay' named entity 'IgG' named entity 'IgM' named entity 'Biotechnology' named entity 'IgG antibodies' named entity 'window period' named entity 'Covid' named entity 'SARS-CoV-2' named entity 'asymptomatic patients' named entity 'clinical signs' named entity 'IgG' named entity 'APACHE II' named entity 'RT-PCR' named entity 'epidemiological' named entity 'TNFα' named entity 'IgM' named entity 'antibodies' named entity 'IgG antibodies' named entity 'serological test' named entity 'rapid test' named entity 'IgG' named entity 'immune response'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software